Key result
The 2017 ACC/AHA hypertension guidelines may result in labeling healthy people as having disease and cause possible adverse treatment effects at lower blood pressure targets.
Key points are not available for this paper at this time.
Design
Editorial
Discusses implications of the 2017 hypertension guidelines, highlighting concerns about labeling healthy people with disease and potential adverse effects of lower targets.
In this Viewpoint, John Ioannidis discusses implications of the 2017 hypertension guidelines for real-world management of blood pressure (BP), including labeling healthy people as having disease and possible adverse treatment effects at lower BP treatment targets..
No takes yet. Share an insight, caveat, or question.
John P. A. Ioannidis (2017) studied this question. The 2017 ACC/AHA hypertension guidelines may result in labeling healthy people as having disease and cause possible adverse treatment effects at lower blood pressure targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: